Fmoc-Lys(Boc)-OH-13C6,15N2 structure
|
Common Name | Fmoc-Lys(Boc)-OH-13C6,15N2 | ||
---|---|---|---|---|
CAS Number | 850080-89-6 | Molecular Weight | 476.48 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C2013C6H3215N2O6 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | N/A | |
Symbol |
GHS09 |
Signal Word | Warning |
Use of Fmoc-Lys(Boc)-OH-13C6,15N2Fmoc-L-Lys (Boc)-OH-13C6,15N2 is a 15N-labeled and 13C-labled Triclabendazole. |
Name | Fmoc-Lys(Boc)-OH-13C6,15N2 |
---|---|
Synonym | More Synonyms |
Description | Fmoc-L-Lys (Boc)-OH-13C6,15N2 is a 15N-labeled and 13C-labled Triclabendazole. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[75]. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Molecular Formula | C2013C6H3215N2O6 |
Molecular Weight | 476.48 |
Exact Mass | 476.24000 |
PSA | 113.96000 |
LogP | 5.45510 |
Index of Refraction | 1.566 |
L-Lysine-13C6-15N2, N6-[(1,1-dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]- |
N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N6-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-(13C6,15N2)lysine |
N6-(tert-Butoxycarbonyl)-N2-{[(9H-fluoren-9-yl)methoxy]carbonyl}-L-(13C6,15N2)lysine |